Supernus Pharm (SUPN) Earnings
|
Expand Research on SUPN
| Next EPS Date | 11/10/26 | EPS Growth Rate | +185.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -285.0% | Revenue Growth Rate | +13.4% |
| Average % Move 1-Wk after EPS | -1.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/26  |
Q326 | N/A | $0.68 | N/A | N/A | $217.79M | = | N/A | N/A | ||
| 8/3/26 |
Q226 | -$1.01 | $0.43 | -$1.44 | $219.1M | $205.63M | = |  | | Details | |
| 5/5/26 |
Q126 | N/A | $0.19 | N/A | N/A | $192.96M | = | N/A | N/A | ||
| 2/24/26 | Q425 | -$0.07 | $0.41 | -$0.48 | $211.6M | $195.48M | = | | | Details | |
| 11/4/25 | Q325 | -$0.80 | $0.14 | -$0.94 | $192.1M | $175.82M | = | | | Details | |
| 8/5/25 | Q225 | $0.40 | $0.48 | -$0.08 | $165.5M | $154.3M | = | | | Details | |
| 5/6/25 | Q125 | -$0.21 | $0.37 | -$0.58 | $149.8M | $146.9M | = | | | Details | |
| 2/25/25 | Q424 | $0.27 | $0.33 | -$0.06 | $174.16M | $150.24M | = | | | Details |
